Inhibition of ATP synthase in Mycobacterium smegmatis inverted membrane vesicles using NADH as substrate incubated for 60 mins by luciferin-luciferase reaction based bioluminescence assay
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harboring ATP synthase subunit-a K179N mutant supplemented with 4 fold MIC of 3-(4-Morpholinophenyl)-4-((pyridin-2-ylmethyl)amino)cyclobut-3-ene-1,2-dione
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harboring ATP synthase subunit-c D28N mutant supplemented with 4 fold MIC of 3-(4-Morpholinophenyl)-4-((pyridin-2-ylmethyl)amino)cyclobut-3-ene-1,2-dione
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harboring ATP synthase subunit-c D28N mutant supplemented with 8 fold MIC of 3-(4-Morpholinophenyl)-4-((pyridin-2-ylmethyl)amino)cyclobut-3-ene-1,2-dione
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv harboring ATP synthase subunit a K179N mutant supplemented with 8 fold MIC of 3-(4-Morpholinophenyl)-4-((pyridin-2-ylmethyl)amino)cyclobut-3-ene-1,2-dione
Antimycobacterial activity against Mycobacterium tuberculosis H37Rv infected in BALB/c mouse assessed as bacterial growth inhibition at 100 to 200 mg/kg, po qd administered every 6 days for 2 weeks
Selectivity ratio of MIC for Mycobacterium tuberculosis H37Rv harboring ATP synthase subunit-a K179N mutant supplemented with 4 fold MIC of 3-(4-Morpholinophenyl)-4-((pyridin-2-ylmethyl)amino)cyclobut-3-ene-1,2-dione to MIC for Mycobacterium tuberculosis H37Rv
Selectivity ratio of MIC for Mycobacterium tuberculosis H37Rv harboring ATP synthase subunit-c D28N mutant supplemented with 4 fold MIC of 3-(4-Morpholinophenyl)-4-((pyridin-2-ylmethyl)amino)cyclobut-3-ene-1,2-dione to MIC for Mycobacterium tuberculosis H37Rv
Selectivity ratio of MIC for Mycobacterium tuberculosis H37Rv harboring ATP synthase subunit-c D28N mutant supplemented with 8 fold MIC of 3-(4-Morpholinophenyl)-4-((pyridin-2-ylmethyl)amino)cyclobut-3-ene-1,2-dione to MIC for Mycobacterium tuberculosis H37Rv
Selectivity ratio of MIC for Mycobacterium tuberculosis H37Rv harboring ATP synthase subunit a K179N mutant supplemented with 8 fold MIC of 3-(4-Morpholinophenyl)-4-((pyridin-2-ylmethyl)amino)cyclobut-3-ene-1,2-dione to MIC for Mycobacterium tuberculosis H37Rv
Ratio of free plasma concentration in BALB/c mouse infected with Mycobacterium tuberculosis H37Rv in absence of pan CYP inhibitor ABT to presence of pan CYP inhibitor ABT
Time required for free plasma concentration to maintain above in vitro MIC for Mycobacterium tuberculosis H37Rv in BALB/c mouse infected with Mycobacterium tuberculosis H37Rv at 100 mg/kg, po in presence of pan CYP inhibitor ABT
Inhibition of ATP synthase in Mycobacterium tuberculosis H37Rv assessed as reduction in bacterial growth incubated for 7 days by microplate alamar blue assay
Inhibition of ATP synthase in multi-drug resistant Mycobacterium tuberculosis clinical isolate 13946 assessed as reduction in bacterial growth incubated for 7 days by microplate alamar blue assay
Inhibition of ATP synthase in multi-drug resistant Mycobacterium tuberculosis clinical isolate 14862 assessed as reduction in bacterial growth incubated for 7 days by microplate alamar blue assay